Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 45 filings·Updated 29 Sept 2026
Showing 10 of 45 filings.
29 Sept 20261 filing
AGM/EGMAGM

Ishan Dyes holds 33rd AGM via VC/OAVM on 29 Sept 2026; two ordinary resolutions placed

AGM Details

  • AGM held on 29 September 2026 at 3:00 PM IST via VC/OAVM; concluded 3:28 PM IST.

Key Resolutions

  • Adoption of standalone financial statements and reports; outcome not disclosed.
  • Re-appointment of Shrinal Patel as Director retiring by rotation; outcome not disclosed.

Director Changes

  • Shrinal P. Patel re-appointed as Whole-Time Director (DIN – 02992519).
Filed 17:01View Source
26 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Ishan Dyes and Chemicals Limited - Trading Window closed from 01 October 2026 till 48 hours after the declaration of Un-Audited Standalone Financial Results for the quarter and half-year ending 30 September 2026

Ishan Dyes and Chemicals Limited - Trading Window closed from 01 October 2026 till 48 hours after the declaration of Un-Audited Standalone Financial Results for the quarter and half-year ending 30 September 2026

Filed 16:23View Source
4 Sept 20261 filing
Company UpdateNewspaper Publication

We are submitting herewith Copies of Newspaper Publication confirming electronic dispatch of Notice of 33rd AGM and Annual Report 2025-26.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 14:29View Source
3 Sept 20262 filings
OthersReg. 34 (1) Annual Report

Ishan Dyes and Chemicals 2025-26: revenue decline with net loss; capital raised via preferential issue; governance flags; listing advance.

Financial performance

  • Sales (Net) ₹7347.13 lakh in FY2025-26, down from ₹10146.96 lakh.
  • Total Revenue ₹7663.63 lakh, down from ₹10446.85 lakh.
  • EBITDA ₹690.41 lakh; prior year ₹971.37 lakh.
  • Profit after tax ₹-710.85 lakh; net loss for the year.
  • Exports turnover ₹1810.51 lakh in FY2025-26.
  • Earnings per share (Basic) ₹-3.00; Diluted ₹-2.99.
  • Net debt ₹8,988.24 lakh; gearing 0.39x.
  • Share capital ₹2,730.44 lakh; reserves ₹11,482.98 lakh.
  • Operating cash flow ₹859.18 lakh; cash & cash equivalents ₹40.38 lakh.

Capital structure and funding

  • Authorized share capital increased to ₹35 crore.
  • Convertible equity warrants up to 45,84,872; price ₹63 each.
  • Equity shares up to 54,15,128; price ₹63 each (including premium).
  • Allotments: 51,72,270 equity shares on 20-Sep-2025.
  • 11,63,980 warrants converted to equity on 21-Mar-2026; 34,20,892 warrants outstanding.
  • On 21-Mar-2026 and 28-Mar-2026, 4,23,280 and 7,40,700 equity shares issued on conversion.
  • Total fund raise ₹63.00 crore; actual utilization ₹45.3013 crore; unutilized ₹17.6987 crore.
  • Listing approvals: 51,72,270 shares listed; approvals for 4,23,280 and 7,40,700 shares in 2026.
  • Demat shareholding 95.73% of issued capital; 2,61,40,417 shares dematerialized.

Dividends & shareholder matters

  • No dividend declared for FY2025-26.
  • Unclaimed dividends: Final 2020 due 7-Oct-2027; Interim 2021 due 23-May-2028.
  • 33rd AGM scheduled 29-Sep-2026 via VC/OAVM.

Operations and outlook

  • Industry remains challenging due to high input costs and inflation.
  • Outlook for 2026-27: volatility; focus on demand protection and cost control.
  • Plan to commence new chemical intermediates plant by end-FY2025-26.
  • Capital expenditure includes Sulphuric Acid-linked unit ₹10,625.31 lakh; CETP ₹36.00 lakh; Green Fantom ₹82.08 lakh.
  • Intangible assets under development include Deep Sea Effluent Pipeline ₹43.09 lakh.

Governance & risk management

  • Board size six; independent directors: Nirmal Tiwari, Darshan Shah, Apexa Panchal.
  • Ronak Desai ceased as Independent Director on 28-Sep-2025.
  • Statutory Auditor: A.R. Sulakhe & Co.; Secretarial Auditor: Kunal Sharma & Associates.
  • Material audit qualifications: impairment on related party loan ₹1,460.22 lakh; NRV inventory ₹2,759.49 lakh.
  • Internal controls: material weakness in impairment assessment; NRV valuations corrective actions noted.

Regulatory & compliance flags

  • Tax and duties disputes: IT demand ₹215.38 lakh; GST ₹453.22 lakh; Customs ₹1791.28 lakh; MSMED ₹15.92 lakh.
  • Contingent liabilities disclosed; uncertain outcomes for tax and duties.
  • Auditors highlighted potential liquidity and covenant considerations; no long-term contract losses reported.

Shareholding & market status

  • Promoters hold 40.15% collectively; Mirali H. Patel 9.77%, Piyush N. Patel 10.11%, Shrinal P. Patel 8.85%, Anilaben 10.86%, Marutbhai 0.56%.
  • Public shareholding 59.85%.
  • Total equity ₹14,213.42 lakh; issued equity shares 27,304,397.
  • Dematerialisation 95.73%; ISINs: equity INE561M01018; warrants INE561M13021.
  • NSE listing for 51,72,270 shares since 29-Jun-2025; further listings approved for 4,23,280 and 7,40,700 shares in 2026.
  • Postal ballot 30-Apr-2026: reappointment of Shrinal P. Patel and Piyush N. Patel.

CSR & sustainability

  • CSR Committee exists; no spend reported for the year; CSR policy available on site.
Filed 13:25View Source
AGM/EGMAGM

Ishan Dyes and Chemicals Ltd to hold 33rd AGM via VC/OAVM on 29 September 2026

AGM details

  • AGM scheduled for 29 September 2026 at 3:00 PM IST via VC/OAVM.
  • Remote e-voting from 26 September 2026, 09:00 IST to 28 September 2026, 17:00 IST.
  • Cut-off date for e-voting eligibility: 22 September 2026.
  • Register of Members and Share Transfer Books closed 23–29 September 2026.

Resolutions

  • Ordinary resolution: Adoption of Audited Standalone Financial Statements and reports thereon.
  • Ordinary resolution: Re-appointment of Shrinal P Patel as Director retiring by rotation.
  • No special business proposed for the AGM.

Director changes

  • Shrinal P Patel to be re-appointed as Director retiring by rotation.
  • Category: Whole Time Director (Promoter and Executive).
  • Remuneration proposed: Not Applicable.
  • Shareholding: 24,15,210 equity shares.
Filed 13:21View Source
22 Aug 20261 filing
Company UpdateNewspaper Publication

We are submitting herewith Copies of Newspaper Publication in respect of information regarding 33rd Annual General Meeting of the Company.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:15View Source
17 Aug 20261 filing
Company UpdateNewspaper Publication

We are submitting herewith disclosure under regulation 30 of SEBI (LODR) Regulations, 2015 - Copies of Newspaper Publication.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:51View Source
14 Aug 20261 filing
ResultFinancial Results

Q1 FY2026-27: Net sales 4148.04 Lakhs; net profit 15.50 Lakhs; AGM on 29 Sep 2026

Financial results

  • Net sales/income from operations: 4148.04 Lakhs for quarter ended 30-06-2026.
  • Total Income: 4284.42 Lakhs for quarter ended 30-06-2026.
  • Cost of materials consumed: 3058.80 Lakhs.
  • Changes in inventories: 360.04 Lakhs.
  • Employee benefits: 169.86 Lakhs.
  • Finance cost: 249.82 Lakhs.
  • Depreciation: 204.51 Lakhs.
  • Other expenses: 223.17 Lakhs.
  • Total expenses: 4266.20 Lakhs.
  • Profit before tax: 18.22 Lakhs.
  • Tax expenses: 2.72 Lakhs.
  • Net profit from continuing operations: 15.50 Lakhs.
  • Other comprehensive income: 6.78 Lakhs.
  • Total comprehensive income: 15.50 Lakhs.
  • EPS (Basic): 0.06 Rs.
  • EPS (Diluted): 0.06 Rs.
  • Paid up equity share capital: 2730.44 Lakhs; face value Rs 10.
  • Auditor: Limited Review with qualified conclusion.
  • One reportable segment: Chemicals.

Board actions & AGM

  • 33rd AGM on 29 Sep 2026 at 3:00 PM IST via video conferencing.
  • Scrutinizer: CS Kunal Sharma appointed.

Comparatives

  • Q1 FY2025: Net sales 1628.83 Lakhs; Total Income 1673.31; Net profit 30.40; EPS 0.14.
Filed 20:02View Source
7 Aug 20261 filing
Board Meeting

Intimation of Aug 14, 2026 board meeting to consider unaudited Q1 June 2026 results; trading window closed

Meeting Details

  • Meeting date: 14 August 2026; time and venue not disclosed.

Key Agenda Items

  • Un-Audited Standalone Financial Results for quarter ended 30 June 2026 to be considered.
  • Any other matter with the permission of the Chair.

Other Notes

  • Trading window closed from 24 June 2026 till 48 hours after declaration of unaudited results.
Filed 13:23View Source
31 Jul 20261 filing
Company UpdateGeneral

Ishan Dyes starts work on four new sulphur-based products in Sulphuric Acid Unit; launch planned in 3 months

Four new sulphur-based products

  • Commenced production activities for four high-value sulphur-based products at the Sulphuric Acid Unit; launch expected within three months.
Filed 11:39View Source
Showing 10 of 45 filings